Subscribe Login

Pasta Maker Barilla Funds Cell Therapy Research For Coronavirus

By Dayeeta Das
Share this article
Pasta Maker Barilla Funds Cell Therapy Research For Coronavirus

The Barilla family, which owns the pasta maker of the same name, has donated $500,000 to US non-profit association 'The Cure Alliance' to fund research on a COVID-19 therapy based on stem cells, the group has said.

The clinical trial for the cure, which is being developed by a group of international scientists led by Italian professor Camillo Ricordi, has already received approval from the US Food and Drug Administration, Barilla said.

A 24-patient clinical trial will be carried out in Miami to assess the efficacy of the therapy aimed at blocking the life-threatening lung inflammation that accompanies severe cases of the disease triggered by the coronavirus.

The money adds to a previous €2 million ($2.19 million) donation made last month by the company to health institutions in Italy to fight the coronavirus outbreak in the company's home country.

News by ReutersClick subscribe to sign up to ESM: European Supermarket Magazine.

Get the week's top grocery retail news

The most important stories from European grocery retail direct to your inbox every Thursday

Processing your request...

Thanks! please check your email to confirm your subscription.

By signing up you are agreeing to our terms & conditions and privacy policy. You can unsubscribe at any time.